-
COST-EFFECTIVENESS OF ELRANATAMAB VERSUS PHYSICIAN’S CHOICE OF TREATMENT FOR TRIPLE-CLASS-EXPOSED MULTIPLE MYELOMA IN JAPAN
Mar 18, 2026, 21:38 PM -
GEOGRAPHIC AND TEMPORAL TRENDS IN ADULT DIABETES PREVALENCE, UNITED STATES, 2011-2021
Mar 18, 2026, 21:38 PM -
MENSTRUAL IRREGULARITY AND M-FRG SCORES: SHARED PREDICTORS OF DIAGNOSED AND HIGH-RISK PCOS IN UNIVERSITY STUDENTS
Mar 18, 2026, 21:38 PM -
POWER, POLITICS, AND PRICE: GOVERNANCE FAILURES IN NEPAL’S PHARMACEUTICAL SYSTEM AND THE UHC CHALLENGE
Mar 18, 2026, 21:38 PM -
COMPARATIVE ANALYSIS OF GENE THERAPIES AUTHORIZED BY THE U.S. FOOD AND DRUG ADMINISTRATION AND THE EUROPEAN MEDICINES AGENCY
Mar 18, 2026, 21:38 PM -
PSYCHOSOCIAL CORRELATES OF HEALTH ANXIETY IN A HEALTHY ADULT POPULATION
Mar 18, 2026, 21:38 PM -
CHARACTERIZATION OF PATIENTS WITH PROSTATE CANCER IN COLOMBIA FROM A REAL-WORLD MULTICENTER FROM A HEALTHCARE RESOURCE UTILIZATION (HRU) STUDY
Mar 18, 2026, 21:38 PM -
TREATMENT DELAYS IN IBD: A MULTI-SITE REAL-WORLD ANALYSIS ACROSS UC HEALTH
Mar 18, 2026, 21:38 PM -
INTERPRETABLE MACHINE LEARNING TO PREDICT CATASTROPHIC HEALTH EXPENDITURE RISK IN CHINA: EVIDENCE FROM NATIONALLY REPRESENTATIVE SURVEY DATA
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION OF SACITUZUMAB GOVITECAN AMONG METASTATIC TRIPLE-NEGATIVE BREAST CANCER PATIENTS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
EVALUATION OF BARIATRIC SURGERY TRENDS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM (2018-2024): REAL WORLD STUDY ASSESSING THE GAP BETWEEN PREVALENCE AND LAPAROSCOPIC UPTAKE
Mar 18, 2026, 21:38 PM -
VALIDATION OF A TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) UNITED STATES (US) CLAIMS-BASED CODING ALGORITHM
Mar 18, 2026, 21:38 PM -
DIGITAL HEALTH FOR HYPERTENSION IN RURAL NORTHERN NIGERIA: REAL-WORLD PATIENT-CENTERED AND ECONOMIC OUTCOMES FROM A MIXED-METHODS STUDY
Mar 18, 2026, 21:38 PM -
WHO IS MOST AT RISK OF UNRECOGNIZED DIABETES? A STUDY TO INFORM PHARMACIST ACTION
Mar 18, 2026, 21:38 PM -
ESTIMATING THE MEDICAL UNMET NEED AND BURDEN OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
Mar 18, 2026, 21:38 PM -
VALUE-BASED DECISION BOUNDARIES ANALYSIS (VB-DBA): A NOVEL METHOD OF INTEGRATING NETWORK META-ANALYSIS AND COST-EFFECTIVENESS MODELLING TO ESTIMATE PRICING THRESHOLDS BASED ON TARGET PRODUCT PROFILES
Mar 18, 2026, 21:38 PM -
SAFETY OF SEPIAPTERIN AND PEGVALIASE FOR THE TREATMENT OF PHENYLKETONURIA (PKU): A SIMULATED TREATMENT COMPARISON (STC)
Mar 18, 2026, 21:38 PM -
VALIDATING PRIMARY AND SECONDARY HEALTHCARE RESOURCE USE AND COSTS ESTIMATES IN OMOP-MAPPED VS SOURCE CPRD-HES DATA IN THE UK
Mar 18, 2026, 21:38 PM -
PATIENT-CENTERED ENDPOINT STRATEGY FOR BIOLOGIC TRIALS IN SEVERE ASTHMA: INTEGRATING REGULATORY, PAYER, AND PATIENT PRIORITIZED ENDPOINTS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF THRUST CHUNA MANUAL THERAPY COMPARED WITH NON-THRUST CHUNA OR USUAL CARE IN PATIENTS WITH NON-ACUTE LOW BACK PAIN
Mar 18, 2026, 21:38 PM
